15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Cabot Corporation, 1 rate it Buy or better, 2 sit at Hold, and 1 rate it Sell or worse, a hold consensus. Targets span $70.00 to $98.00, a moderate spread. The average target of $86.00 sits 6% below the current $91.04. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 0 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.53 next quarter toward $7.03 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Hold
Strong Buy00%
Buy125%
Hold250%
Sell125%
Strong Sell00%
Based on 4 analysts giving stock ratings to Cabot Corporation.
As of Jul, 1 of 4 firms rate CBT a Buy (2 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
CBT EPS & revenue forecast
EPS · NEXT QUARTER
$1.53
Range $1.43 – $1.63 · 6 analysts · -10% YoY
Next period, 6 analysts expect Cabot Corporation to earn $1.53 a share (range $1.43 – $1.63), versus $1.70 a year earlier. Full-year consensus is $6.33, growing to $7.03 the year after.
REVENUE · NEXT QUARTER
$916.2M
Range $887.2M – $964.7M · 6 analysts · +2% YoY
Revenue is expected to reach $916.2M (range $887.2M – $964.7M), +1.9% year-over-year. Full-year consensus is $3.6B, rising to $3.7B next year.
Top analysts covering Cabot Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CBT.
#1
Joshua Spector
UBS · Rank #48
Hold
$86.00-5.5% to target
Overall win rate
50%
+ Follow
#2
Jeffrey Zekauskas
JP Morgan · Rank #53
Sell
$70.00-23.1% to target
Overall win rate
54%
+ Follow
#3
DB
David Begleiter
Deutsche Bank · Rank #282
Hold
$80.00-12.1% to target
Overall win rate
31%
+ Follow
#4
John Roberts
Mizuho
Hold
$90.00-1.1% to target
Coverage
—
+ Follow
#5
PO
Peter Osterland
Truist Securities
Buy
$98.00+7.6% to target
Coverage
—
+ Follow
CBT stock forecast FAQ
What is CBT's average 12-month price target?+
The 4 analysts with a live target average $86.00 for Cabot Corporation over the next 12 months, ranging from a $98.00 high to a $70.00 low.
Is CBT stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 4 analyst ratings, 1 are Buy or Strong Buy, 2 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for CBT?+
The Street-high target is $98.00 (Truist Securities), and the Street-low is $70.00 (JP Morgan). The average of all 4 active targets is $86.00.
How many Wall Street analysts cover CBT?+
4 analysts have an active rating on Cabot Corporation, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering CBT?+
Among analysts who currently cover CBT, Joshua Spector of UBS has the strongest overall Quantellect track record (Rank #48). Their current call is Hold with a $86.00 target.
What is Cabot Corporation's projected EPS for next quarter?+
The consensus estimate is $1.53 per share (range $1.43 – $1.63) across 6 analysts. Full-year EPS is projected at $6.33, rising to $7.03 the following year.
How much revenue is Cabot Corporation expected to report next quarter?+
Consensus revenue is $916.2M (range $887.2M – $964.7M). Full-year revenue is projected at $3.6B, growing to $3.7B next year.
Have analysts been upgrading or downgrading CBT lately?+
As of Jul, 1 of 4 firms rate CBT a Buy (2 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CBT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
